Pharmacology and Family Medicine Update for Primary Care is organized by MCE Conferences. The session is held from Jul 10 - 12, 2020 at Omni Hilton Head Oceanfront Resort, Hilton Head Island, South Carolina, United States of America. This session has been approved for a maximum of 12 Prescribed credits by the American Academy of Family Physicians.
All Physicians and other Healthcare Professionals endeavoring clinical information about Pharmacology and Family Medicine.
This is designed to provide primary care clinicians with up-to-date, evidence-based information on commonly faced issues in Pharmacology and Family Medicine for Primary Care while suggesting practical approaches to clinical management. The discussion-based format of the conference will stimulate audience participation through dynamic lectures, case-based studies, and hands-on workshops. Keynote speakers will present and critically evaluate current progress and industry updates in Pharmacology and Family Medicine, with the goal of enhancing the knowledge-base and core competence of attendees. The successful completion of this interactive program diagnosing, treating, and prescribing the most effective courses of treatment, with the ultimate goal of improving patient outcomes.
Topics and Objectives:
Drug Therapy for the Prevention and Treatment of Osteoporosis
Objectives: 1) Define treatment goals for patients with or at-risk for osteoporosis 2) Relate treatment strategies to empiric evidence regarding fracture prevention and treatment for women and men 3) Develop a prevention and monitoring plan for patients at-risk for osteoporosis 4) Describe pertinent pharmacologic parameters related to pharmaceuticals used in the prevention and treatment of osteoporosis
Optimizing Psychopharmacotherapy in Depression: Clinical Cases
Objectives: 1) Discuss pharmacologic management options within clinical cases of patients with depression 2) Relate physiologic and pathophysiologic alterations of brain neurochemistry to symptoms of depression, including the genetic link and molecular basis of injury 3) Apply clinical practice guidelines for antidepressant therapies 4) Describe key parameters for medications used to treat mechanism, safety, tolerability, efficacy, cost, and simplicity of use Optimizing
Psychopharmacotherapy in Bipolar Disorder: Clinical Cases
Objectives: 1) Discuss pharmacologic management options within clinical cases of patients with bipolar disorder 2) Relate physiologic and pathophysiologic alterations of brain neurochemistry to symptoms of bipolar disorder or psychosis, including the genetic link and molecular basis of injury 3) Apply clinical practice guidelines for mood stabilizer therapies 4) Describe key parameters for medications used to treat mechanism, safety, tolerability, efficacy, cost, and simplicity of use
Optimizing Drug Therapy and Avoiding Drug Injury in the Older Adult, Part 1
Objectives: 1) Discuss key physiologic and pathophysiologic changes of aging that impact drug therapy 2) Apply age-sensitive principles for medication dosing and management to patient scenarios 3) Discuss high-risk drug-drug and drug-dietary supplement interactions commonly encountered in primary care, including best practices in identifying and managing related toxicities
Optimizing Drug Therapy and Avoiding Drug Injury in the Older Adult, Part 2
Objectives: 1) List 9 key questions useful for identifying and managing polypharmacy in older adults 2) Apply practical tools to screen and appropriately manage complex drug regimens among older adults with or at-risk for drug injury in case study scenarios
Best Practices in Prescribing Opioids: A Regulatory Perspective
Objectives: 1) Describe evolving opioid prescribing and regulatory practices in the United States 2) Discuss most recent opioid prescribing guidelines, highlighting the relevance to primary care providers 3) Describe best practices for managing patients with chronic nonmalignant pain, highlighting guidance from a regulatory perspective
Chronic Obstructive Pulmonary Disease
Objectives: 1) Define treatment goals for patients with Chronic Obstructive Pulmonary Disease 2) Discuss evidence-based recommendations and guidelines for diagnosing, treating and controlling Chronic Obstructive Pulmonary Disease 3) Develop a drug therapy and monitoring plan for patients with Chronic Obstructive Pulmonary Disease 4) Identify strategies to support patient education and adherence within inhaled medications for Chronic Obstructive Pulmonary Disease.
Obstructive Sleep Apnea
Objectives: 1) Identify the pathophysiology and comorbidities often associated with Obstructive Sleep Apnea 2) Discuss lifestyle, medication, biomechanical and surgical options for the treatment of Obstructive Sleep Apnea.
Common Office Emergencies
Objectives: 1) Identify the most common office emergencies encountered in the primary care setting 2) Develop immediate action plans to address the most common office emergencies, to include appropriate medication, equipment and staff training 3) Discuss ways in which the primary care provider can either initiate or integrate into already established national, state and local community resilience efforts
Inflammatory and Infectious Conditions of the Gastrointestinal Tract
Objectives: 1) Discuss principles of antimicrobial therapy and the major classes of antibacterial agents in gastrointestinal tract infections 2) Apply evidence-based approaches to diagnosis and select appropriate antimicrobial alternatives for common gastrointestinal infections in primary care 3) Describe novel laboratory and diagnostic tools for rapid identification of causative agents in common infections in primary care 4) Discuss inflammatory conditions found in the gastrointestinal tract 5) Choose appropriate drug therapies in the management of common inflammatory diseases in special populations and vulnerable patients; and 6) Apply practical tools to identify and treat common infections and inflammatory diseases encountered in clinical practice in case study scenarios
Management of Lipids (Cholesterol) and CVD Risk
Objectives: 1) Understand the strengths and limitations of Risk Assessment and identify a few handy tools 2) Learn the benefits of statins (including high and low doses), how to discuss these benefits with patients, and how to manage the muscle ache worry 3) Review the other interventions for lipids and evolving guideline recommendations
Type 2 Diabetes
Objectives: 1) Discuss the complexity (harms and benefits) of sugar targets in Type 2 diabetes (who benefits with which targets) 2) Review the high-level evidence for available therapies to reduce sugar (including the long acting insulins) 3) Learn which adjunctive therapies (example blood pressure) provide the best risk reductions in diabetic patients
Note: Content is subject to change without notice. Please refer to the activity website for the most current information.
|Contact No. :||1 888 533 9031
|Registration Type||Last Date||Price|
|Physician - Early Fee||02 Jun,2020||USD 750.00|
|Military MD/Residents/Other Healthcare Professionals - Early Fee||02 Jun,2020||USD 650.00|